INOVIQ Ltd (ASX:IIQ) Insider Buys A$56,756.35 in Stock

INOVIQ Ltd (ASX:IIQ) insider Robert (Max) Johnston purchased 162,161 shares of the stock in a transaction dated Friday, March 7th. The shares were purchased at an average cost of A$0.35 ($0.22) per share, for a total transaction of A$56,756.35 ($35,695.82).

INOVIQ Price Performance

The company has a current ratio of 7.07, a quick ratio of 9.52 and a debt-to-equity ratio of 2.02. The firm has a market cap of $47.40 million, a price-to-earnings ratio of -6.02 and a beta of 2.04.

INOVIQ Company Profile

INOVIQ Ltd engages in the research, development, and commercialization of diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. The company offers hTERT test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET for capturing and isolating exosomes from liquid biopsy sample.